Los Angeles Capital Management
VYGR icon

Los Angeles Capital Management’s Voyager Therapeutics VYGR Stock Holding History

Los Angeles Capital Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,180
Closed -$50.3K – 1554
2025
Q2 		$50.3K Buy
+16,180
New +$52.2K ﹤0.01% 1304
2021
Q2 		– Sell
-60,228
Closed -$284K – 1680
2021
Q1 		$284K Sell
60,228
-45,895
-43% -$313K ﹤0.01% 1449
2020
Q4 		$759K Sell
106,123
-17,215
-14% -$165K ﹤0.01% 1047
2020
Q3 		$1.32M Buy
123,338
+2,783
+2% +$32.7K 0.01% 713
2020
Q2 		$1.52M Buy
120,555
+33,598
+39% +$391K 0.01% 702
2020
Q1 		$796K Buy
86,957
+37,497
+76% +$430K 0.01% 768
2019
Q4 		$690K Buy
49,460
+36,770
+290% +$534K ﹤0.01% 932
2019
Q3 		$218K Hold
12,690
– – ﹤0.01% 1193
2019
Q2 		$345K Buy
+12,690
New +$290K ﹤0.01% 1151

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Los Angeles Capital Management's VYGR Position: Q3 2025 in Review

Los Angeles Capital Management sold out of Voyager Therapeutics (VYGR) in Q3 2025, closing a stake of 16,180 shares — an estimated $50.3K sold.

Los Angeles Capital Management first reported a position in VYGR in Q2 2019 and held it in 9 quarters. The position peaked at $1.52M in Q2 2020. 117 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.

  • Los Angeles Capital Management reported no remaining Voyager Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Los Angeles Capital Management sold 16,180 Voyager Therapeutics shares in Q3 2025, an estimated $50.3K.
  • Los Angeles Capital Management first reported a position in Voyager Therapeutics in Q2 2019 and held it in 9 quarters.
  • Los Angeles Capital Management's Voyager Therapeutics position peaked at $1.52M in Q2 2020.
  • 117 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.

Based on Los Angeles Capital Management's 13F filing for Q3 2025, filed 20 Oct 2025.